Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Claessens

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2016
Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total TestosteroneLeen Antonio, Frederick C W Wu, Terence W O'Neill, et al.
Age and Ageing|December 31, 2013
Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European menDavid M Lee, Dirk Vanderschueren, Steven Boonen, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Cancers|April 23, 2022
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer StatusHui-Yi Lin, Tung-Sung Tseng, Xinnan Wang, et al.
EMBO Reports|October 18, 2021
The androgen receptor depends on ligand-binding domain dimerization for transcriptional activationSarah El Kharraz, Vanessa Dubois, Martin E van Royen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2013
Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS)Dirk Vanderschueren, Stephen R Pye, Terence W O'Neill, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2015
Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European menLeen Antonio, Frederick C W Wu, Terence W O'Neill, et al.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2016
Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total TestosteroneLeen Antonio, Frederick C W Wu, Terence W O'Neill, et al.
Age and Ageing|December 31, 2013
Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European menDavid M Lee, Dirk Vanderschueren, Steven Boonen, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Cancers|April 23, 2022
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer StatusHui-Yi Lin, Tung-Sung Tseng, Xinnan Wang, et al.
EMBO Reports|October 18, 2021
The androgen receptor depends on ligand-binding domain dimerization for transcriptional activationSarah El Kharraz, Vanessa Dubois, Martin E van Royen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2013
Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS)Dirk Vanderschueren, Stephen R Pye, Terence W O'Neill, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2015
Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European menLeen Antonio, Frederick C W Wu, Terence W O'Neill, et al.
The Prostate|May 6, 2021
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancerVictoria Wang, Milan S Geybels, Kristina M Jordahl, et al.
Pageof 18